Abstracts

Citation

K Rough, GR Seage III, PL Williams, S Hernandez-Diaz, Y Huo, EG Chadwick, RM Hoffman, E Barr, ED Shapiro, K Patel. TDF/FTC in pregnancy shows no increase in adverse infant birth outcomes in US cohorts. Presented at: CROI 2018.

Citation

B Best, E Capparelli, A Stek, E Acosta, E Smith, N Chakhtoura, J Wang, A Hernandez, M Mirochnick. Elvitegravir/cobicistat pharmacokinetics in pregnancy and postpartum. Presented at: CROI 2017; 2017 Feb 16.

Citation

Patricia Flynn, Tahah Taha, Mae Cababasay, Kevin Butler, Mary Glenn Fowler, Lynne Mofenson, Mazensia Owor, Susan Fiscus, Lynda Stranix-Chibanda, Anna Coutsoudis, Devasena Gnanashanmugam, Nahida Chakhtoura, Katie McCarthy, Cornelius Mukuzunga, Bonus Makanani, Dhayendre Moodley , Teacler Nematadzira, Bangini Kusakara, Sandesh Patil, Tichaona Vhembo, Raziya Bobat, Blandina Mmbaga, Maysseb Masenya, Mandisa Nyati, Gerhard Theron, Helen Mulenga, David Shapiro, The PROMISE study team. Association of Maternal Viral Load and CD4 Count with Perinatal HIV-1 Transmission Risk during Breastfeeding in the PROMISE Postpartum Component. Presented at: IAS 2018.

Citation

Michael Boivin, Limbika Maliwichi-Senganimalunje, Lillian Wambuzi Ogwang, Rachel Kawalazira, Alla Sikorskii, Itziar Familiar-Lopez, Agatha Kuteesa, Mary Nyakato, Alex Mutebe, Mai Nakitende, MacPherson Mallewa, Horacio Ruisenor-Escudero, Jim Aizire, Taha Taha, Mary Glenn Fowler. Developmental and cognitive effects of type of antepartum and postpartum ARV exposure for Ugandan and Malawian PROMISE HIV-exposed versus unexposed children at age 12, 24, and 48 months. Presented at: IAS 2018.

Citation

Cindy Vavro, Ted Ruel, Andrew Wiznia, Carmelita Alvero, Stephanie Popson, Terry Fenton, Rohan Hazra, Ellen Townley, Ann Buchanan, Paul Palumbo. Emergence of Resistance in HIV-1 Integrase (IN) Following Dolutegravir (DTG) Treatment in 6 to 18 Year Old Participants Enrolled in the P1093 Study. Presented at: IAS 2018.

Citation

Alfred Saah, Myron J Levin, Sharon Huang, Anna-Barbara Moscicki, Lin-Ye Song, Jennifer S Read, William A Meyer, Kelly Richardson, AdrianaWeinberg for the IMPAACT P1085 Protocol Team. Four-Year Persistence of Type-Specific Immunity After Administration of Quadrivalent Human Papillomavirus Vaccine to HIV-infected Children: Effect of a Fourth Dose. Presented at: IVP 2017.

Citation

P Krogstad, P Samson, T Meyers, E Acosta, J Moye, E Townley, S Bradford, L Marillo, K Denson, L Hovind, T Sise, H Teppler, S Dittmer, L Fairlie, A Hesseling, M Cotton. P1101: Phase I/II Study of Raltegravir-Containing Regimen in HIV and TB Co-Treated Children Aged 6-12 Years. Presented at: 10th International Workshop on HIV Pediatrics; 2018 Jul 20.

Citation

David Bearden, Alexander J. Gill, Paige L. Williams, Dennis L. Kolson, Laura Schankel, Allison Agwu, Russell B. Van Dyke, Steven D. Douglas. Biomarkers of Cognitive Decline in Perinatally Infected Children with HIV. Presented at: CROI 2017; 2017 Feb 14.

Citation

Itziar Familiar, Miiam Chernoff, Horacio Ruisenor-Escudero, Barbara Laughton, Celeste Joyce, Lee Fairlie, Bwkura-Dangarembizi Mutsa, Portia Kamthunzi, Linda Barlow, Patrick Jean-Philippe, Bonnie Zimmer, Katie McCarthy, Michael Boivin. Caregiver depression and child neuropsychological outcomes in an observational study carried out in four Sub-Saharan countries. Presented at: AIDS 2018; 2018 Jul 24.

Citation

EG Chadwick, C Tierney, A Coletti, MF Cotton, TD Ruel, CA Reding, B Zimmer, M Qin, P Jean-Philippe, R Hazra, C Jackson, S Spector, EV Capparelli, M Mirochnick, LT Purdue, D Costello, C Jennings, K Luzuriaga, C Perlowski, M Bakkura-Dangarembizi, KL Naidoo, J Aizire, D Persaud, Y Bryson for the IMPAACT P1115 team. Asymptomatic Hematologic Toxicity with Very Early Combination Antiretroviral Therapy (cART) in In Utero HIV-infected Infants. Presented at: IAS 2017.